SPC539

Elinzanetant eða lyfjafræðilega viðunandi salt þar af / Elinzanetant or a pharmaceutically acceptable salt thereof

  • Status:
    Umsókn
  • Application date:
    23.1.2026
  • Application published:
    11.2.2026
  • Medicine name:
    Lynkuet
  • Medicine for children:
    No

Timeline

Today
23.1.2026Application
11.2.2026Publication

Marketing license

    • Foreign authorization number:
      EU/1/25/1991
    • Date:
      17.11.2025

    Owner

    • Name:
      KaNDy Therapeutics Limited
    • Address:
      400 South Oak Way, Reading, Berkshire GB

    Agent

    • Name:
      Árnason Faktor ehf.
    • Address:
      Guðríðarstíg 2-4, 113 Reykjavík

    Patent

    Upload documents